S21-152 CORONAVIRUS NEUTRALIZING COMPOSITIONS AND ASSOCIATED METHODS Technology Reference CZB-213S Stanford ref. no. S21-152 Researchers at CZ Biohub SF and Stanford have developed unique fusion proteins that have broad therapeutic benefits for the treatment of infection by existing and future coronaviruses. Payton Weidenbacher Peter Kim